Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma

NCT00006216 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Malignant Mesothelioma

Interventions

BIOLOGICAL: PA-1-STK ovarian carcinoma vaccine
DRUG: ganciclovir

Sponsor

Louisiana State University Health Sciences Center in New Orleans